Table 2 Category 2 Delphi statements (n=19): rated as ‘important’ but ‘not feasible’
Delphi statement numberCategory 2 statementsImportance median scoreFeasibility median scoreSource: NICESource: MTA/TexasSource: stakeholderSource: study team
7Drug treatment should only be offered to children together with behavioural management advice8.56.5
9Children with mild/moderate ADHD should be offered behaviour therapy/parent training before a trial of medication is considered7.55
54Monitoring of improvement/adverse-effects using telephone/SMS or email contact with the parent/young person should occur weekly during the titration phase7.54.5
83During the first 6 months (of medication maintenance) clinic follow-up should be every 3 months8.58
98Heart rate and blood pressure should be monitored after each dose change99
100Heart rate and blood pressure should be recorded on a centile chart8.56
26Information sheets describing all available potential ADHD medications should be routinely provided to parents, young people (>11) and teachers8.56.5
27An information sheet on the medication to be prescribed should be routinely provided to parents, young people (>11), GPs and teachers97.8
30A designated individual (teacher/SENCO) within a school should be identified to provide feedback and liaison86
31For children in secondary school, more than one teacher's view should be acquired7.85
42A side-effect rating scale should be completed before initiation of medication7.36
52During titration, the child should be seen in clinic on a monthly basis87
10All pre-school children with ADHD should be offered behaviour therapy/parent training before a trial of medication is considered94
12In children with comorbid ODD/CD or mood disorders, ADHD medication should be used together with psychological interventions87
34The Conners short form (26 item) should be completed by parents at baseline (pre-medication)98
37The Conners short form (26 item) should be completed by teachers at baseline (pre-medication)8.55.5
40The Conners short form (26 item) self-report should be completed by young people (>11 years) at baseline (pre-medication)75
73At the end of the titration phase the side-effect scale should be repeated by parents76
76At the end of the titration phase the Conners short form (26 item)should be repeated by TEACHERS73
  • ADHD, attention-deficit hyperactivity disorder; CD, conduct disorder; GP, general practitioner; MTA, Multimodal Treatment of ADHD; NICE, National Institute for Health and Care Excellence; ODD, oppositional defiant disorder; SENCO, special educational needs coordinator; Texas, Texas Children's Medication Algorithm Project.

    The statements are based on information from their ascribed source; they have not been taken verbatim from each source.